Orange Book product · Brand (NDA)
JUXTAPID
LOMITAPIDE MESYLATE
At a glance
Feb 25, 2026
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 25, 2026
4 mo ago
Today
Patent 7932268 expires
Listed method-of-use patent (U-1316) expiration.
Aug 19, 2027
in 1 yr 2 mo
Exclusivity ends · NS
New strength exclusivity (3 years)
Feb 25, 2029
in 2 yr 9 mo
Patent 12472172 expires
Listed method-of-use patent (U-4438) expiration.
Jul 29, 2041
in 15 yr 4 mo
Pharmaceutical detail
Active ingredient
LOMITAPIDE MESYLATE
Strength
EQ 2MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 203858
Product number
007
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (1)
- NSNew strength exclusivity (3 years)
Feb 25, 2029
in 2 yr 9 mo
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7932268 | Aug 19, 2027 | in 1 yr 2 mo | U-1316 |
| 12472172 | Jul 29, 2041 | in 15 yr 4 mo | U-4438 |
